Categories: News

Reliefband® Launches Interchangeable Smart Watch Bands to Extend Compatibility to Apple and Samsung Watches

HORSHAM, Pa., Oct. 28, 2021 /PRNewswire-PRWeb/ — Reliefband, an innovator in wearable technology that prevents and treats nausea and vomiting symptoms, launched new Reliefband® Sport Watch Connectors designed specifically for Apple and Samsung watch owners. Available now, the new watch bands are priced at $29.99 each and offered in two color choices (grey or black). The watch bands can be configured to seamlessly attach to an Apple or Samsung watch. With this interchangeable band, an Apple or Samsung watch is situated on top of a user’s wrist with the Reliefband Sport® aligned on the underside of the wrist so it can deliver side effect-free therapy.

Launched last quarter, Reliefband® Sport is a new waterproof wearable therapeutic device that prevents and treats nausea and vomiting associated with motion sickness, morning sickness from pregnancy, anxiety, hangovers, physician-diagnosed migraines, chemotherapy, and as an adjunct to antiemetics in treating post-operative nausea.

Reliefband Sport® is a clinically proven wearable which includes a built-in rechargeable battery that, when fully charged, will last 30 hours on the medium intensity level. Six intensity levels can be quickly toggled allowing users to find the precise setting that’s optimal for their needs at any moment. With the Sport model’s smart sensing technology, the device will turn off after 60 seconds if skin contact is not detected in order to preserve battery life.

The result of more than 20 years of clinical research, Reliefband’s FDA-cleared, patented technology uses accurately programmed pulses with a highly specific waveform, frequency, and intensity to stimulate the median nerve on the underside of the wrist. This precise activity uses the body’s natural neural pathways to block waves of nausea produced by the stomach.

Reliefband will demonstrate Reliefband Sport® and new Reliefband® Sport Watch Connectors at this week’s Pepcom’s Holiday Spectacular! media event.

About Reliefband®

Reliefband is a world leader in neuromodulation and wearable technology. The company’s patented, clinically proven wearable solution quickly prevents and effectively treats nausea and vomiting. Its unique, FDA-cleared neuromodulation technology was originally developed for use in hospitals and alters nerve activity through targeted delivery of gentle pulses to the underside of the wrist to “turn off” feelings of nausea and vomiting. Reliefband is a drug-free alternative that eliminates the discomfort associated with nausea and vomiting. The Reliefband wearable solution has been an industry leader for more than 20 years and is available OTC, at Reliefband.com and Amazon.com. For more information, visit http://www.Reliefband.com.

Media Contact

Mark Tordik, Reliefband, +1 732-763-3078, mtordik@broadpathpr.com

 

SOURCE Reliefband

Staff

Recent Posts

Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

10 minutes ago

Functional Brands Inc. Launches Kirkman’s(R) Skin, Beauty & Anti-Aging Bundle: A Science-Backed Approach to Radiant, Resilient Skin

Comprehensive Formula Featuring Reduced Glutathione, Zinc Cream, Biotin, and Grapefruit Seed ExtractLake Oswego, Oregon--(Newsfile Corp.…

10 minutes ago

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces…

1 hour ago

XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments

Multi-jurisdiction trademark coverage reinforces XRP Healthcare's position across digital health, pharmacy networks, and XRP-based payment…

2 hours ago

Black Book Poll: “Governed AI” Emerges as the Deciding Factor in 2026 NHS Procurement

Respondents report approvals and evaluation readiness are now the bottlenecks driving demand for reusable safety…

2 hours ago

Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares

LONDON, UK / ACCESS Newswire / December 22, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the…

2 hours ago